Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 11 studies | 34% ± 12% | |
endothelial cell | 10 studies | 27% ± 9% | |
oligodendrocyte precursor cell | 10 studies | 34% ± 17% | |
astrocyte | 10 studies | 31% ± 13% | |
glutamatergic neuron | 9 studies | 38% ± 24% | |
GABAergic neuron | 8 studies | 41% ± 21% | |
interneuron | 6 studies | 43% ± 24% | |
microglial cell | 6 studies | 24% ± 5% | |
neuron | 5 studies | 33% ± 13% | |
epithelial cell | 5 studies | 21% ± 3% | |
retina horizontal cell | 5 studies | 23% ± 9% | |
ciliated cell | 5 studies | 26% ± 11% | |
macrophage | 5 studies | 21% ± 5% | |
amacrine cell | 4 studies | 20% ± 4% | |
endothelial cell of lymphatic vessel | 4 studies | 18% ± 1% | |
fibroblast | 4 studies | 21% ± 6% | |
type II pneumocyte | 4 studies | 21% ± 7% | |
GABAergic interneuron | 3 studies | 25% ± 5% | |
granule cell | 3 studies | 23% ± 4% | |
retinal ganglion cell | 3 studies | 24% ± 4% | |
retinal bipolar neuron | 3 studies | 17% ± 1% | |
GABAergic amacrine cell | 3 studies | 22% ± 9% | |
OFF-bipolar cell | 3 studies | 22% ± 7% | |
ON-bipolar cell | 3 studies | 22% ± 7% | |
glycinergic amacrine cell | 3 studies | 22% ± 5% | |
retinal rod cell | 3 studies | 19% ± 2% | |
rod bipolar cell | 3 studies | 27% ± 8% | |
club cell | 3 studies | 26% ± 11% | |
type I pneumocyte | 3 studies | 23% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 3131.69 | 2642 / 2642 | 100% | 33.71 | 704 / 705 |
prostate | 100% | 1800.75 | 245 / 245 | 99% | 30.52 | 499 / 502 |
breast | 100% | 2084.52 | 459 / 459 | 99% | 44.89 | 1107 / 1118 |
thymus | 100% | 2123.98 | 653 / 653 | 99% | 27.73 | 597 / 605 |
adrenal gland | 100% | 3368.20 | 258 / 258 | 97% | 34.21 | 223 / 230 |
kidney | 100% | 1118.98 | 89 / 89 | 97% | 19.39 | 873 / 901 |
lung | 99% | 1551.39 | 575 / 578 | 97% | 18.98 | 1124 / 1155 |
pancreas | 100% | 1007.35 | 327 / 328 | 96% | 14.52 | 170 / 178 |
esophagus | 99% | 1197.22 | 1435 / 1445 | 93% | 13.50 | 171 / 183 |
skin | 97% | 892.83 | 1755 / 1809 | 93% | 19.45 | 438 / 472 |
ovary | 100% | 2378.34 | 180 / 180 | 90% | 9.06 | 386 / 430 |
intestine | 100% | 2181.43 | 966 / 966 | 89% | 12.03 | 468 / 527 |
stomach | 100% | 1052.32 | 358 / 359 | 88% | 10.63 | 253 / 286 |
bladder | 100% | 1753.48 | 21 / 21 | 88% | 11.81 | 444 / 504 |
uterus | 100% | 2168.01 | 170 / 170 | 86% | 10.78 | 394 / 459 |
liver | 96% | 573.73 | 217 / 226 | 67% | 6.73 | 272 / 406 |
blood vessel | 100% | 1450.32 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1486.08 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 1794.75 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 1237.18 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 1261.11 | 845 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 12.47 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 80% | 10.49 | 64 / 80 |
tonsil | 0% | 0 | 0 / 0 | 73% | 6.69 | 33 / 45 |
peripheral blood | 36% | 369.58 | 331 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0005975 | Biological process | carbohydrate metabolic process |
GO_0000139 | Cellular component | Golgi membrane |
GO_0047186 | Molecular function | N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity |
Gene name | CASD1 |
Protein name | N-acetylneuraminate 9-O-acetyltransferase (EC 2.3.1.45) (CAS1 domain-containing protein 1) (Sialate O-acetyltransferase) (SOAT) CAS1 domain containing 1 |
Synonyms | C7orf12 Nbla04196 |
Description | FUNCTION: O-acetyltransferase that catalyzes 9-O-acetylation of sialic acids . Sialic acids are sugars at the reducing end of glycoproteins and glycolipids, and are involved in various processes such as cell-cell interactions, host-pathogen recognition . . |
Accessions | ENST00000443644.1 Q96PB1 F8WDQ7 C9JDR3 ENST00000297273.9 ENST00000447923.5 |